News
The U.S. Diabetes Prevention Program, or DPP, reported on April 28 the 21-year follow-up of a randomized clinical trial, ...
More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health ...
Opioids, antidepressants, and some NSAIDs increase the risk of constipation. Find out which ones do and what helps bowel ...
Advancing diabetes therapy requires an integrative approach that uses emerging technologies. This research topic focuses on the synergy between ...
Carnegie Mellon researchers have used FRESH 3D bioprinting to create the first collagen-based microphysiologic systems, ...
Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...
The proportion of adolescents living with overweight and obesity in England increased by 50% over 15 years, and many related ...
The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...
Medications taken for weight loss are starting to impact wedding planning — and perhaps nothing more than the dress fitting.
Mounjaro (tirzepatide) is quickly becoming a breakthrough option for people managing type 2 diabetes and those seeking ...
There is a low incidence rate of suicide-related adverse events among adults with diabetes or obesity being treated with GLP-1 RAs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results